ARTICLE | Clinical News
TheraSphere regulatory update
August 5, 2013 7:00 AM UTC
The U.K.'s NICE issued guidance recommending the use of selective internal radiation therapy (SIRT), which includes BTG's TheraSphere, for patients with primary hepatocellular carcinoma or those with ...